News & Events
iCAD & ProFound Breast Health Suite in the News
Press Releases
iCAD’s AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare
NASHUA, N.H., Nov. 28, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader in innovative cancer-detection solutions, today announced that key artificial intelligence (AI) powered solutions from iCAD’s ProFound Breast Health Suite are the first applications to be offered in GE HealthCare’s new MyBreastAI Suite* offering. As breast…
iCAD’s ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease
NASHUA, N.H. – Nov. 27, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader in innovative cancer-detection solutions, will present new studies validating its artificial intelligence (AI) powered ProFound Breast Health Suite for uncovering hidden heart or vascular disease and predicting a woman’s risk for developing breast cancer…
iCAD and CancerIQ Announce Partnership to Integrate AI-Enabled Technology With Best-in-Class Risk Assessment and Care Management Platform Offering A Comprehensive Breast Health Care Solution
NASHUA, NH, and CHICAGO, Nov. 20, 2023 — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader in innovative cancer-detection solutions, and CancerIQ, the precision cancer prevention platform streamlining provider workflows and activating high-risk patients, today announced a new partnership to create a best-in-class breast health care solution. The partnership…
In the Media
GE HealthCare integrates iCAD ProFound into new breast cancer detection offering
DOT Med
RSNA23: iCAD, GE HealthCare Integrate to Advance Breast Cancer Detection with AI
HIT Consultant
Upcoming Tradeshows & Meetings
From Pixels to Practice: Harnessing Innovations in Breast AI to Improve Patient Outcomes
Dr. Emily Conant, Professor of Radiology and Vice Chair of Faculty Development in the Department of Radiology at the University of Pennsylvania, Perelman School of Medicine
Webinars
Symposium, JFR21 Intelligence artificielle pour le cancer du sein : révolution actuelle et future pour un meilleur dépistage
Samedi 8 octobre Le Pr Bruno Boyer, CIMI, Paris explique le rôle et l’impact clinique de l’utilisation des solutions d’intelligence artificielle d’iCAD en pratique quotidienne à travers des exemples de cas cliniques et le Pr Corinne Balleyguier de l’Institut Gustave Roussy présente les résultats d’études cliniques montrant les performances des…
ProFound Insights, ProFound Impact: How Cleveland Clinic is Finding the Breast Cancers Radiologists Fear the Most
Thursday, July 20, 2023 While radiologists are trained experts in detecting breast cancer, certain types of tumors are still difficult to detect due to their elusive nature. Join us for a compelling discussion with Dr. Laura Dean, a renowned breast radiologist at the Cleveland Clinic, who will share how iCAD’s…
ProFound Insights, ProFound Impact: Elevating Accuracy Across the Board at Boca Raton Regional Hospital
Wednesday, May 24, 2023 Kathy Schilling, MD, Medical Director, Boca Raton Regional Hospital, recently presented data at the ECR demonstrating how ProFound AI helped nine dedicated breast radiologists find 23% more cancers, without increasing the rate of recalls. Join us as we sit down with Dr. Schilling to discuss what…
Contact Us
Together, we can create a world where cancer can’t hide.
Ready to experience how ProFound can save lives?